Genetic variant in 8q24 is associated with prognosis for gastric cancer in a Chinese population

Journal of Gastroenterology and Hepatology (Australia)

Volumn 30, Issue 4, 2015, Pages 689-695

  Ma, Gaoxiang ^a,b   Gu, Dongying ^c   Lv, Chunye ^d   Chu, Haiyan ^a,b   Xu, Zhi ^c   Tong, Na ^a,b   Wang, Meilin ^a,b   Tang, Cuiju ^c   Xu, Yong ^c   Zhang, Zhengdong ^a,b   Wang, Baolin ^e   Chen, Jinfei ^c  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Nanjing Medical University   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

^d THE AFFILIATED JIANGNING HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^e THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Gastric cancer; Genetic variation; Molecular epidemiology; Survival

Indexed keywords

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER RISK; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CHINESE; CLINICAL FEATURE; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; ASIAN CONTINENTAL ANCESTRY GROUP; CHROMOSOME 8; GENETICS; MORTALITY; PATHOLOGY; PROGNOSIS; RISK; RNA SPLICING; RNA STABILITY; STOMACH TUMOR; SURVIVAL RATE;

LONG UNTRANSLATED RNA; MESSENGER RNA;

ASIAN CONTINENTAL ANCESTRY GROUP; CHROMOSOMES, HUMAN, PAIR 8; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LYMPHATIC METASTASIS; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK; RNA SPLICING; RNA STABILITY; RNA, LONG NONCODING; RNA, MESSENGER; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 84924809725     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12801     Document Type: Article

References (42)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J. Clin. 2011; 61: 69-90.
2. Nagini S. Carcinoma of the stomach: a review of epidemiology, pathogenesis, molecular genetics and chemoprevention. World J. Gastrointest. Oncol. 2012; 4: 156-169.
3. Gudmundsson J, Sulem P, Manolescu A etal. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat. Genet. 2007; 39: 631-637.
4. Haiman CA, Le Marchand L, Yamamato J etal. A common genetic risk factor for colorectal and prostate cancer. Nat. Genet. 2007; 39: 954-956.
5. Schumacher FR, Feigelson HS, Cox DG etal. A common 8q24 variant in prostate and breast cancer from a large nested case-control study. Cancer Res. 2007; 67: 2951-2956.
6. Yeager M, Chatterjee N, Ciampa J etal. Identification of a new prostate cancer susceptibility locus on chromosome 8q24. Nat. Genet. 2009; 41: 1055-1057.
7. Easton DF, Pooley KA, Dunning AM etal. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007; 447: 1087-1093.
8. Kiemeney LA, Thorlacius S, Sulem P etal. Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat. Genet. 2008; 40: 1307-1312.
9. Zanke BW, Greenwood CM, Rangrej J etal. Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat. Genet. 2007; 39: 989-994.
10. He J, Wilkens LR, Stram DO etal. Generalizability and epidemiologic characterization of eleven colorectal cancer GWAS hits in multiple populations. Cancer Epidemiol. Biomarkers Prev. 2011; 20: 70-81.
11. Tomlinson I, Webb E, Carvajal-Carmona L etal. A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat. Genet. 2007; 39: 984-988.
12. Turnbull C, Ahmed S, Morrison J etal. Genome-wide association study identifies five new breast cancer susceptibility loci. Nat. Genet. 2010; 42: 504-507.
13. Kim HC, Lee JY, Sung H etal. A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Study. Breast Cancer Res. 2012; 14: R56.
14. Guttman M, Amit I, Garber M etal. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 2009; 458: 223-227.
15. Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell 2009; 136: 629-641.
16. Rinn JL, Kertesz M, Wang JK etal. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007; 129: 1311-1323.
17. Khalil AM, Guttman M, Huarte M etal. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc. Natl. Acad. Sci. U S A 2009; 106: 11667-11672.
18. Gupta RA, Shah N, Wang KC etal. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010; 464: 1071-1076.
19. Kogo R, Shimamura T, Mimori K etal. Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res. 2011; 71: 6320-6326.
20. Kim K, Jutooru I, Chadalapaka G etal. HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene 2013; 32: 1616-1625.
21. Zhu Z, Gao X, He Y etal. An insertion/deletion polymorphism within RERT-lncRNA modulates hepatocellular carcinoma risk. Cancer Res. 2012; 72: 6163-6172.
22. Chung S, Nakagawa H, Uemura M etal. Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibility. Cancer Sci. 2011; 102: 245-252.
23. Li L, Sun R, Liang Y etal. Association between polymorphisms in long non-coding RNA PRNCR1 in 8q24 and risk of colorectal cancer. J. Exp. Clin. Cancer Res. 2013; 32: 104-110.
24. Lochhead P, Ng MT, Hold GL etal. Possible association between a genetic polymorphism at 8q24 and risk of upper gastrointestinal cancer. Eur. J. Cancer Prev. 2011; 20: 54-57.
25. Wang M, Bai J, Tan Y etal. Genetic variant in PSCA predicts survival of diffuse-type gastric cancer in a Chinese population. Int. J. Cancer 2011; 129: 1207-1213.
26. Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 2000; 56: 337-344.
27. Zheng SL, Sun J, Wiklund F etal. Cumulative association of five genetic variants with prostate cancer. N. Engl. J. Med. 2008; 358: 910-919.
28. Gruber AR, Lorenz R, Bernhart SH, Neubock R, Hofacker IL. The Vienna RNA websuite. Nucleic Acids Res. 2008; 36: W70-74.
29. Halvorsen M, Martin JS, Broadaway S, Laederach A. Disease-associated mutations that alter the RNA structural ensemble. PLoS Genet. 2010; 6: e1001074.
30. Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol. Cell. 2011; 43: 904-914.
31. Tsai MC, Manor O, Wan Y etal. Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010; 329: 689-693.
32. Kastler S, Honold L, Luedeke M etal. POU5F1P1, a putative cancer susceptibility gene, is overexpressed in prostatic carcinoma. Prostate 2010; 70: 666-674.
33. Pomerantz MM, Ahmadiyeh N, Jia L etal. The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat. Genet. 2009; 41: 882-884.
34. Tuupanen S, Turunen M, Lehtonen R etal. The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling. Nat. Genet. 2009; 41: 885-890.
35. Harismendy O, Frazer KA. Elucidating the role of 8q24 in colorectal cancer. Nat. Genet. 2009; 41: 868-869.
36. de Souza CR, Leal MF, Calcagno DQ etal. MYC deregulation in gastric cancer and its clinicopathological implications. PLoS ONE 2013; 8: e64420.
37. Guo Y, Fang J, Liu Y etal. Association between polymorphism rs6983267 and gastric cancer risk in Chinese population. World J. Gastroenterol. 2011; 17: 1759-1765.
38. Uemura N, Mukai T, Okamoto S etal. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol. Biomarkers Prev. 1997; 6: 639-642.
39. You WC, Brown LM, Zhang L etal. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J. Natl. Cancer Inst. 2006; 98: 974-983.
40. Fukase K, Kato M, Kikuchi S etal. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008; 372: 392-397.
41. Take S, Mizuno M, Ishiki K etal. Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases. J. Gastroenterol. 2007; 42 (Suppl. 17): 21-27.
42. Wang C, Yuan Y, Hunt RH. The association between Helicobacter pylori infection and early gastric cancer: a meta-analysis. Am. J. Gastroenterol. 2007; 102: 1789-1798.